Delivery Order SPE2DB24D2205-SPE2DB25FEEKY
- Not listed
- The Defense Logistics Agency (DLA) awarded a $2,458.75 delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in 100-gram units, with an ultimate completion date of September 12, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation, performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Pimecrolimus 1% Cream in a 30-gram quantity, valued at $20,510.86. This delivery order, issued on September 11, 2025, represents a firm fixed-price contract with an ultimate completion date of September 12, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp will perform the work at its corporate office location in Conshohocken, Pennsylvania....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,534.08 by the Defense Logistics Agency on August 19, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram quantities. The contract utilizes firm fixed pricing and carries an ultimate completion date of August 20, 2025. This competitively awarded delivery order, which includes no set-aside designation, is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $1,002.95 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,887.66 to AmerisourceBergen Drug Corp for the supply of Pimecrolimus 1% Cream in 30-gram units. This firm fixed price, non-competitive delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The pharmaceutical product will be delivered to the prime contractor's location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,739.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of PIMECROLIMUS 1% Cream (30 grams). This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $10,804.84 and an ultimate completion date of May 2, 2025. This is a firm fixed-price delivery order under a non-set-aside competitive procurement, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply action supporting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Pimecrolimus 1% Cream in 100-gram units. This contract, valued at $3,265.16, represents a firm fixed-price delivery order with an ultimate completion date of August 11, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- This is a $8,995.16 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 15, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support...
- This is a $1,139.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 100 gram tubes of Pimecrolimus 1% cream. The contract has an ultimate completion date of July 3, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEKYDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 2, 2025, for the supply of Pimecrolimus 1% Cream in 30-gram units, with a ceiling value of $1,484.50. This firm fixed-price delivery order, with an ultimate completion date of July 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made through competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and a primary distribution hub for federal pharmaceutical procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through its comprehensive $999,999,999.00 IDC with DLA Troop Support Medical running through December 2026. This prime vendor contract enables the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The delivery order for Pimecrolimus reflects AmerisourceBergen's role in fulfilling specialized dermatological pharmaceutical needs across the federal supply chain, consistent with the company's demonstrated capability to manage competitively awarded delivery orders across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 7/2/25 |